Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 79 users online. 2 members and 77 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

6 results in 0.0105 seconds.
Keywords
Members
Tags
Moderna x
  •  

  • National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes

    National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes | site |



    NIH says "Data from Phase 3 clinical trial confirm vaccine is effective".


    (Information contained in National Institutes of Health [NIH] press release dated: December 30, 2020)

    The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD). The vaccine was co-developed by Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. ...
    See more | Go to post

  • FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States

    FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States | site |



    Company to begin transporting first Moderna COVID-19 vaccine shipments for McKesson Corp.


    (Information contained in FedEx press release dated: December 19, 2020)

    Memphis, Tenn. December 19, 2020 – FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the world’s largest express transportation company, announced today that operations are in motion to transport Moderna’s COVID-19 vaccines for McKesson Corp. throughout the United States. Following the Food and Drug Administration’s approval of Emergency Use Authorization for the Moderna COVID-19 vaccine, FedEx Express will begin transport of the vaccine and kits of supplies for administration of the vaccine, using its FedEx Priority Overnight® service supported by FedEx Priority Alert® advanced monitoring. After months of preparation and close planning with McKesson, Operation W...
    See more | Go to post

  • U.S. Department of Health and Human Services publishes Statements on FDA Authorization of Moderna Vaccine

    U.S. Department of Health and Human Services publishes Statements on FDA Authorization of Moderna Vaccine | site |



    (The following information was contained in a U.S. Department of Health and Human Services [HHS] press release dated: December 18, 2020)



    HHS and DoD Statements on FDA Authorization of Moderna Vaccine



    On Friday, the Food and Drug Administration announced that it had issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, the second COVID-19 vaccine to receive an EUA. Operation Warp Speed has allocated more than 5.9 million doses of the vaccine for jurisdictions to receive in the coming week. Below are statements from HHS Secretary Alex Azar and Acting Defense Secretary Christopher Miller. “On January 7, before China had reported even one death from the novel coronavirus or confirmed human-to-human transmission, NIH scientists and innovators at Moderna agreed to b...
    See more | Go to post

  • NIH publishes Statement on the FDA Emeregency Use Authorization of the Moderna COVID-19 Vaccine

    National Institutes of Health publishes Statement on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine| site |


    (The following is information contained in a National Institutes of Health [NIH] press release dated: December 18, 2020)


    Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine


    Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, for its COVID-19 vaccine, which was co-developed with scientists at the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). This innovative and monumental partnership has enabled NIH and Moderna to develop a safe and effective COVID-19 vaccine within the span of a year that will be manufactured and distributed across the U.S. The vaccine, called mRNA-1273, is a messenger...
    See more | Go to post

  • Trump Administration Purchases additional 100 Million Doses of COVID-19 Investigational Vaccine from Moderna

    Trump Administration Purchases additional 100 Million Doses of COVID-19 Investigational Vaccine from Moderna |site |



    (Information contained in U.S. Department of Health and Human Services press release: December 11, 2020)

    The Trump Administration, through the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD), will purchase an additional 100 million doses of COVID-19 vaccine candidate, called mRNA-1273, from Moderna.

    If authorized by the U.S. Food and Drug Administration for emergency use as outlined in agency guidance, doses of the vaccine will begin shipping immediately. The vaccine would be provided at no cost to Americans. Vaccine administration costs for private-sector administration partners will be covered by healthcare payers: private insurance, Medicare or Medicaid, and an HHS program to cover COVID-19 costs for the uninsured which is reimbursing the provider at Medicare rates from the
    ...
    See more | Go to post

  • HHS Secretary Azar Statement on Moderna Vaccine Announcement

    HHS Secretary Azar Statement on Moderna Vaccine Announcement

    U.S. Department of Health and Human Services Secretary Azar Statement on Moderna Vaccine Announcement | site |



    (November 16, 2020) - - Today the U.S. Department of Health and Human Services (HHS) published the following information:


    HHS Secretary Azar Statement on Moderna Vaccine Announcement

    On Monday, the National Institutes of Health announced that an independent data and safety monitoring board’s interim review of data from Moderna’s investigational COVID-19 vaccine suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults. HHS Secretary Alex Azar issued the following statement: “The Moderna/NIH vaccine candidate is now the second vaccine to show the potential for very high efficacy in Phase 3 trials. Operation Warp Speed has provided about $2 billion in funding and operational support for development, manufacturing, and eventual potential delivery of the Moderna/NIH vaccine. Th...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes
    by Staff Reporter 1
    National Institutes of Health says Peer-reviewed Report on Moderna COVID-19 Vaccine Publishes | site |



    NIH says "Data from Phase 3 clinical trial confirm vaccine is effective".


    (Information contained in National Institutes of Health [NIH] press release dated: December 30, 2020)

    The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD). The vaccine was co-developed by Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. ...
    01-02-2021, 07:44 PM
  • Staff Reporter 1
    FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States
    by Staff Reporter 1
    FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States | site |



    Company to begin transporting first Moderna COVID-19 vaccine shipments for McKesson Corp.


    (Information contained in FedEx press release dated: December 19, 2020)

    Memphis, Tenn. December 19, 2020 – FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and the world’s largest express transportation company, announced today that operations are in motion to transport Moderna’s COVID-19 vaccines for McKesson Corp. throughout the United States. Following the Food and Drug Administration’s approval of Emergency Use Authorization for the Moderna COVID-19 vaccine, FedEx Express will begin transport of the vaccine and kits of supplies for administration of the vaccine, using its FedEx Priority Overnight® service supported by FedEx Priority Alert® advanced monitoring. After months of preparation and close planning with McKesson, Operation W...
    12-27-2020, 04:20 AM
  • Staff Reporter 1
    U.S. Department of Health and Human Services publishes Statements on FDA Authorization of Moderna Vaccine
    by Staff Reporter 1
    U.S. Department of Health and Human Services publishes Statements on FDA Authorization of Moderna Vaccine | site |



    (The following information was contained in a U.S. Department of Health and Human Services [HHS] press release dated: December 18, 2020)



    HHS and DoD Statements on FDA Authorization of Moderna Vaccine



    On Friday, the Food and Drug Administration announced that it had issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, the second COVID-19 vaccine to receive an EUA. Operation Warp Speed has allocated more than 5.9 million doses of the vaccine for jurisdictions to receive in the coming week. Below are statements from HHS Secretary Alex Azar and Acting Defense Secretary Christopher Miller. “On January 7, before China had reported even one death from the novel coronavirus or confirmed human-to-human transmission, NIH scientists and innovators at Moderna agreed to b...
    12-22-2020, 06:14 PM
  • Staff Reporter 1
    NIH publishes Statement on the FDA Emeregency Use Authorization of the Moderna COVID-19 Vaccine
    by Staff Reporter 1
    National Institutes of Health publishes Statement on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine| site |


    (The following is information contained in a National Institutes of Health [NIH] press release dated: December 18, 2020)


    Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine


    Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, for its COVID-19 vaccine, which was co-developed with scientists at the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). This innovative and monumental partnership has enabled NIH and Moderna to develop a safe and effective COVID-19 vaccine within the span of a year that will be manufactured and distributed across the U.S. The vaccine, called mRNA-1273, is a messenger...
    12-21-2020, 10:33 PM
  • Staff Reporter 1
    Trump Administration Purchases additional 100 Million Doses of COVID-19 Investigational Vaccine from Moderna
    by Staff Reporter 1
    Trump Administration Purchases additional 100 Million Doses of COVID-19 Investigational Vaccine from Moderna |site |



    (Information contained in U.S. Department of Health and Human Services press release: December 11, 2020)

    The Trump Administration, through the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD), will purchase an additional 100 million doses of COVID-19 vaccine candidate, called mRNA-1273, from Moderna.

    If authorized by the U.S. Food and Drug Administration for emergency use as outlined in agency guidance, doses of the vaccine will begin shipping immediately. The vaccine would be provided at no cost to Americans. Vaccine administration costs for private-sector administration partners will be covered by healthcare payers: private insurance, Medicare or Medicaid, and an HHS program to cover COVID-19 costs for the uninsured which is reimbursing the provider at Medicare rates from the
    ...
    12-12-2020, 04:00 AM

Menu

Collapse

Menu

Collapse

Working...
X